Phibro Animal Health (NASDAQ:PAHC) will be announcing its earnings results after the market closes on Monday, February 5th. Analysts expect the company to announce earnings of $0.39 per share for the quarter. Phibro Animal Health has set its FY18 guidance at $1.55-1.61 EPS.
Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Monday, November 6th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. Phibro Animal Health had a net margin of 8.87% and a return on equity of 42.75%. The business had revenue of $193.40 million during the quarter, compared to the consensus estimate of $189.89 million. During the same quarter last year, the company earned $0.36 earnings per share. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Shares of Phibro Animal Health (NASDAQ PAHC) opened at $34.05 on Friday. Phibro Animal Health has a 1 year low of $26.65 and a 1 year high of $40.25. The company has a debt-to-equity ratio of 1.91, a quick ratio of 1.85 and a current ratio of 3.26. The firm has a market cap of $1,370.00, a P/E ratio of 20.03, a PEG ratio of 3.99 and a beta of 1.18.
A number of analysts have recently weighed in on PAHC shares. Zacks Investment Research raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 price target for the company in a research report on Tuesday, October 31st. Piper Jaffray Companies set a $41.00 price target on shares of Phibro Animal Health and gave the stock a “buy” rating in a research report on Friday, October 6th. ValuEngine downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Thursday, November 9th. Finally, BidaskClub downgraded shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 2nd. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $38.25.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/03/phibro-animal-health-pahc-set-to-announce-quarterly-earnings-on-monday.html.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.